Canterbury DHB

Context

Indications for Evogam

For replacement therapy only

Evogam is immunoglobulin for subcutaneous use.

A weekly dose in the range of 0.05–0.15 g/kg body weight is recommended.

Evogam is administered as a slow push or via an infusion pump at an infusion rate of 10 mL/hr. This may be gradually increased after the first completed infusion up to 20 mL/hour as comfort and tolerability allows. Larger doses (>20 mL) should be divided and given at different sites.

See the links below for further information:

See the prescription chart for Evogam

About this Canterbury DHB document (120965):

Document Owner:

Not assigned (see Who's Who)

Issue Date:

August 2014

Next Review:

August 2016

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 120965